US › Healthcare

Adlai Nortye Ltd. American Depositary Shares (ANL)

US · Healthcare · Biotechnology

$15.28-1.55%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$7.3M

Revenue YoY

+885.2%

Net profit

$-2.7M

EPS

$0.00

EPS estimate

$0.00

Net margin

-36.3%

Key statistics

Market cap

$979.5M

Forward P/E

0.0

P/B

4.61

Book value

$3.34

EPS (TTM)

$-0.66

52-week high

$17.25

52-week low

$0.88

50-day MA

$12.89

200-day MA

$9.27

Beta

1.10

Analyst view

Analysts rate Adlai Nortye Ltd. American Depositary Shares a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $29.20.

Shareholding

Insiders

1.06%

Institutions

45.20%

Largest institutional holders

Fund	Stake
VR Adviser, LLC	8.03%
Cormorant Asset Management, LLC	7.24%
MPM Oncology Impact Management LP	4.84%
Perceptive Advisors LLC	4.48%
Casdin Capital, LLC	3.12%
Octagon Capital Advisors LP	2.34%
Balyasny Asset Management LLC	2.19%
Millennium Management LLC	2.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Adlai Nortye Ltd. American Depositary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.